Hugh Montgomery OBE | |
---|---|
Born | Hugh Edward Montgomery 20 October 1962 [1] |
Alma mater | Middlesex Hospital Medical School |
Known for | "Fitness gene" |
Scientific career | |
Fields | Medicine, Climate Change |
Institutions | University College London |
Website | twitter |
Hugh Edward Montgomery OBE (born 20 October 1962) is an English professor of medicine and the director of the Centre for Human Health and Performance at University College London. He discovered that an allele of the gene with the DNA code for angiotensin-converting enzyme (ACE) influences physical fitness; this was the first discovery of a gene related to fitness. [2] [3]
Montgomery was educated at Plymouth College. He obtained a 1st Class BSc degree in 1984 in neuropharmacology and cardiorespiratory physiology, before qualifying as a medical doctor in July 1987 from the Middlesex Hospital Medical School, University of London. [4] He was awarded the prize as most outstanding student during this time. In 1997, he was awarded his higher research degree (MDRes) for work on paracrine renin-angiotensin systems. He now directs the UCL centre for Human Health and Performance. He has authored nearly 500 research papers in journals such as Nature, The Lancet and the New England Journal of Medicine. [2] [5] [6] [7] [8] and has received 11 national and international awards. His work has ranged from the development and application of gene-environment interaction studies (reporting the 'first gene for human physical performance'), to population genetic studies (being amongst the first to identify signatures of selection for high altitude amongst Tibetans) and work in artificial intelligence. He was research lead for the 2008 Xtreme Everest research expedition. He co-chairs the Lancet Countdown on Health and Climate Change, having co-chaired several previous commissions on the subject.
He is a Professor of Intensive Care Medicine at UCL and practises as a consultant in critical care at the Whittington Hospital in north London. [9] [10]
Montgomery was appointed Officer of the Order of the British Empire (OBE) in the 2022 New Year Honours for services to intensive care medicine and climate change. [11]
Montgomery is an established and outspoken critic of people taking public healthcare risks during the Coronavirus pandemic. He aired his concerns publicly during the first wave of COVID-19 infections both in the UK and Australia. During these televised interviews he answered questions and issued advice on the subject.
During the UK's second wave of COVID-19 cases, in interviews with the BBC Radio 5 Live and Channel 4 news, Montgomery strongly criticized the public for not practising social distancing and wearing masks, declaring them as "having blood on their hands". [12] [13]
Since 1998, Hugh has been active in trying to address the health impacts of climate change. He initiated the First Lancet Commission on the subject in 2008, and led the first international conference on its Health and Security implications. He co-chairs the annual 47-country Lancet Countdown on Health & Climate Change. He’s written & lectured extensively on the subject; has briefed policymakers (inter)nationally; and co-leads the UCL MSc module on Climate & Health. He sits on University College London's 'Climate Change' Grand Challenge Steering Committee, and co-leads Sustainability for the UK Intensive Care Society. He was appointed London Leader by Greater London Authority’s Sustainable Development Commission; has attended many of the international ‘COP’ negotiations; founded the children’s climate education ‘Project Genie’; and co-led the ITV documentary on Floods and Climate Change (2020). He was awarded the OBE in 2022 in part for his work on climate change and health. In 2024, he founded the non-profit Real Zero, helping to reduce emissions through activity in the health sector.
Montgomery held a Cat X skydiving qualification, and also an HSE Pt IV commercial diving licence. He is a keen snorkeller and mountain walker, and has climbed in the Himalaya (Cho Oyu, 8201m, 2006; Pumori), the European Alps, and the Andes (Aconcagua, 6997m).
Montgomery has been awarded the title of London Leader by the London Sustainable Development Commission for his work in climate change and health under the auspices of Project Genie; he was also a founding member of the UK Climate and Health Council and one of the co-authors of the UCL-Lancet Commission in 2009. Montgomery has complemented his interest in fitness with achievements which include the 100 km ultra marathons, holding the world record for underwater piano playing as well as visiting Everest with the Xtreme Everest research group to undertake research. [14]
He was the co-Editor-in-Chief of the Open Access journal Extreme Physiology & Medicine published by BioMed Central. [15]
Montgomery is the author of the children's book The Voyage of the Arctic Tern . [16] He has also authored the children's book Cloudsailors and, in 2019, the medical thriller 'Control', described by Lynda la Plante as 'A suspenseful and frightening medical thriller'.
He is an inventor, holding patents relating to new uses for renin-angiotensin antagonists in metabolic regulation; for a new fluid delivery device; and for a new asthma inhaler device.
He appeared on BBC Radio 4's Desert Island Discs in 2014, and was the subject of The Life Scientific in 2012.
Angiotensin is a peptide hormone that causes vasoconstriction and an increase in blood pressure. It is part of the renin–angiotensin system, which regulates blood pressure. Angiotensin also stimulates the release of aldosterone from the adrenal cortex to promote sodium retention by the kidneys.
Sir Salvador Enrique Moncada Seidner, FRS, FRCP, FMedSci is a Honduran-British pharmacologist and professor. He is currently Research Domain Director for Cancer at the University of Manchester.
Perindopril is a medication used to treat high blood pressure, heart failure, or stable coronary artery disease. As a long-acting ACE inhibitor, it works by relaxing blood vessels and decreasing blood volume. As a prodrug, perindopril is hydrolyzed in the liver to its active metabolite, perindoprilat. It was patented in 1980 and approved for medical use in 1988.
Hugh Redmond Brady is an Irish academic, the 17th President of Imperial College London, and a professor of medicine. He was the 13th President and Vice-Chancellor of the University of Bristol. He is also President Emeritus of University College, Dublin (UCD), having served as UCD's eighth President from 2004 to 2013.
Kevin Jeremy San Yoong Fong is a British doctor and broadcaster. He is a consultant anaesthetist and anaesthetic lead for Major Incident Planning at UCL Hospitals. He is a professor at University College London where he organises and runs an undergraduate course Extreme Environment Physiology. Fong also serves as a prehospital doctor with Air Ambulance Kent Surrey Sussex and specialises in space medicine in the UK and is the co-director of the Centre for Aviation Space and Extreme Environment Medicine, University College London.
Sir Andrew Paul Haines, FMedSci is a British epidemiologist and academic. He was the Director of the London School of Hygiene & Tropical Medicine from 2001 to 2010.
Janusz Jankowski is a doctor, educationalist and scientist of Scottish Polish origin He is an expert in Social and Healthcare Policy, Academic Management and Global Research and Education Networks He was formerly in previous senior management roles including Deputy Vice Chancellor of Research and Innovation, Pro Vice Chancellor Research, Vice Dean Research and the Sir James Black Professorship. He is father to three children, including son and Semi-Pro hockey player Jakob Jankowski.
Michael M. Meguid is Professor of Surgery Emeritus at Upstate Medical University in Syracuse, New York. He is the founder and editor-in-chief of Nutrition: The International Journal of Applied and Basic Nutrition Sciences.
Sir Alimuddin Zumla,, FRCP, FRCPath, FRSB is a British-Zambian professor of infectious diseases and international health at University College London Medical School. He specialises in infectious and tropical diseases, clinical immunology, and internal medicine, with a special interest in HIV/AIDS, respiratory infections, and diseases of poverty. He is known for his leadership of infectious/tropical diseases research and capacity development activities. He was awarded a Knighthood in the 2017 Queens Birthday Honours list for services to public health and protection from infectious disease. In 2012, he was awarded Zambia's highest civilian honour, the Order of the Grand Commander of Distinguished services - First Division. In 2023, for the sixth consecutive year, Zumla was recognised by Clarivate Analytics, Web of Science as one of the world's top 1% most cited researchers. In 2021 Sir Zumla was elected as Fellow of The World Academy of Sciences.
Didier Pittet is an infectious diseases expert and the director of the Infection Control Programme and WHO Collaborating Centre on Patient Safety, University Hospital of Geneva, Geneva, Switzerland. Since 2005, Pittet is also the External Lead of the World Health Organization (WHO) Global Patient Safety Challenge "Clean Care is Safer Care" and African Partnerships for Patient Safety.
Elizabeth Matilda "Tilli" Tansey is a British neurochemist who is an Emerita Professor of the history of medicine and former neurochemist, best known for her role in the Wellcome Trust's witness seminars. She previously worked at Queen Mary University of London (QMUL).
Annette Catherine Dolphin is a British scientist who is Professor of Pharmacology in the Department of Neuroscience, Physiology and Pharmacology at University College London (UCL).
Patrick John Thompson Vallance, Baron Vallance of Balham, is a British physician, scientist, Life Peer, and clinical pharmacologist who serves as Minister of State for Science in the Department for Science, Innovation and Technology since July 2024. He previously served as HM Government chief scientific adviser from 2018 to 2023.
Joy Elizabeth Lawn is a British paediatrician and professor of maternal, reproductive and child health. She is Director of the London School of Hygiene & Tropical Medicine Maternal, Adolescent, Reproductive & Child Health (MARCH) Centre. She developed the epidemiological evidence for the worldwide policy and programming that looks to reduce neonatal deaths and stillbirths and works on large-scale implementation research.
Christina Pagel is a German-British mathematician and professor of operational research at University College London (UCL) within UCL's Clinical Operational Research Unit (CORU), which applies operational research, data analysis and mathematical modelling to topics in healthcare. She was Director of UCL CORU from 2017 to 2022 and is currently Vice President of the UK Operational Research Society. She also co-leads, alongside Rebecca Shipley, UCL's CHIMERA research hub which analyses data from critically ill hospital patients.
Mike Grocott is professor of anaesthesia and critical care medicine at the University of Southampton and director of the National Institute for Health and Care Research's (NIHR) Southampton Biomedical Research Centre (2022-27). He is an NIHR Senior Investigator (2018-26) and was national specialty group lead for Anaesthesia Perioperative Medicine and Pain within the NIHR Clinical Research Network (2015-2021). He is a consultant in critical care medicine at University Hospital Southampton NHS Foundation Trust.
Ibrahim Ibrahim Abubakar is a British-Nigerian epidemiologist who is Professor in Infectious Disease Epidemiology, Pro-Provost (Health) and Dean of the Faculty of Population Health Sciences at University College London.
Lucilla Poston is a physiologist specialising in problems during pregnancy. She is a professor of maternal and fetal health at King's College London.
Rachel Louise Batterham is a British physician who is a professor of Obesity, Diabetes and Endocrinology at University College London. She established the University College London Hospitals NHS Foundation Trust Bariatric Centre for Weight Management and Metabolic Surgery. She has extensively studied obesity, and has contributed to clinical management and the understanding of obesity-related diseases.
Atul Malhotra is the director of research for pulmonary, critical care, sleep medicine, and physiology at the University of California, San Diego's Medical School. In addition, he is the Peter C. Farrell Presidential Chair and tenured professor of medicine at the same university. He is the author of almost 800 research publications, reviews, and book chapters.